22 January 2025
At the meeting of 3 December 2024 the RMA:
Determined Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| polymyalgia rheumatica | 5/2025 | 6/2025 |
| ganglion | 7/2025 | 8/2025 |
| peritoneal adhesions | 9/2025 | 10/2025 |
| arachnoid cyst | 11/2025 | 12/2025 |
| benign prostatic hyperplasia | 13/2025 | 14/2025 |
| eating disorder | 15/2025 | 16/2025 |
| Lyme disease/Lyme borreliosis | 17/2025 | 18/2025 |
These SOPs revoke the SOPs previously determined for these conditions.
Determined New Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| traumatic brachial plexopathy | 1/2025 | 2/2025 |
| distal biceps brachii tendinopathy | 3/2025 | 4/2025 |
The above SOPs take effect from 28 January 2025.
Completed Investigations
The above determinations conclude the previously advertised investigations into:
New Investigation
Decided to advertise the following investigation:
- cardiomyopathy (focused - infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19))
The above investigation notice appears in the Government Notices Gazette of 18 December 2024.